H1 Revenues of $7.6 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / May 14, 2026 / Microbix…
Selective oral NMDA receptor modulator demonstrated favorable safety, tolerability, and pharmacokinetic profile supporting planned Phase 2a development in chemotherapy-induced peripheral…
DALLAS, TX / ACCESS Newswire / May 14, 2026 / Consumer Choice Award is proud to announce that Terminix has…
TORONTO, ON / ACCESS Newswire / May 14, 2026 / Consumer Choice Award is proud to announce that Toronto Comfort…
BRAMPTON, ON / ACCESS Newswire / May 14, 2026 / Consumer Choice Award is proud to announce that Little Galaxy…
MARKHAM, ON / ACCESS Newswire / May 14, 2026 / Consumer Choice Award is proud to announce that The Renovators…
NEW YORK CITY, NY / ACCESS Newswire / May 14, 2026 / Vero Technologies, a leading provider of modular lending…
TORONTO, ON / ACCESS Newswire / May 14, 2026 / Consumer Choice Award is proud to announce that E.W. Smith…
Oversubscribed $22.5 million financing anticipated to enable CNS Pharmaceuticals to acquire differentiated, clinical-stage assets with identifiable near-term value-inflection catalysts, aligned…
A New Domain-Specific Model Trained on Marketing Frameworks, Brand Voice Patterns and Engagement Psychology. Not an AI Wrapper. MIAMI, FL…